Impact of invasive fungal infection on outcomes of severe sepsis: A multicenter matched cohort study in critically ill surgical patients

Critical Care

Volumn 12, Issue 1, 2008, Pages

  Xie, Guo Hao ^a   Fang, Xiang Ming ^a   Fang, Qiang ^a   Wu, Xin Min ^b   Jin, Yu Hong ^c   Wang, Jun Lu ^d   Guo, Qu Lian ^e   Gu, Miao Ning ^f   Xu, Qiu Ping ^g   Wang, Dong Xin ^b   Yao, Shang Long ^h   Yuan, Shi Ying ^h   Du, Zhao Hui ⁱ   Sun, Yun Bo ^j   Wang, Hai Hong ^g   Wu, Shui Jing ^a   Cheng, Bao Li ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

^c NINGBO UNIVERSITY   (China)

^d WENZHOU MEDICAL UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f SOUTHERN MEDICAL UNIVERSITY   (China)

^g ZHEJIANG UNIVERSITY   (China)

^h HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

ⁱ WUHAN UNIVERSITY   (China)

^j QINGDAO UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CORTICOSTEROID; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE;

ADULT; AGED; APACHE; ARTERY CATHETERIZATION; ARTICLE; ARTIFICIAL VENTILATION; CANDIDA ALBICANS; CENTRAL VENOUS CATHETERIZATION; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; FUNGAL DETECTION; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HOSPITAL COST; HUMAN; INTENSIVE CARE; INVASIVE MYCOSIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYCOSIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SUPERINFECTION; SURGICAL PATIENT; URETER CATHETERIZATION; CLASSIFICATION; CLINICAL TRIAL; HOSPITALIZATION; INTENSIVE CARE UNIT; MEDICAL RECORD; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE COMPLICATION; STATISTICAL MODEL;

AGED; APACHE; COHORT STUDIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; MYCOSES; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 38849192321     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc6766     Document Type: Article

References (39)

1. Eggimann P Garbino J Pittet D: Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003, 3:685-702. 10.1016/S1473-3099(03)00801-6 14592598
2. Fisher-Hoch SP HutwagAer L: Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995, 21:897-904 8645837
3. Fridkin SK Jarvis WR: Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996, 9:499-511. 172907 8894349
4. Vincent JL Sakr Y Sprung CL Ranieri VM Reinhart K Gerlach H Moreno R Carlet J Le Gall JR Payen D: Sepsis in European intensive care units: results of the SOAP study Crit Care Med 2006, 34:344-353. 10.1097/ 01.CCM.0000194725.48928.3A 16424713
5. Brun-Buisson C Doyon F Carlet J Dellamonica P Gouin F Lepoutre A Mercier JC Offenstadt G Regnier B: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units. JAMA 1995, 274:968-974. 10.1001/ jama.274.12.968 7674528
6. Sands KE Bates DW Lanken PN Graman PS Hibberd PL Kahn KL Parsonnet J Panzer R Orav EJ Snydman DR Black E Schwartz JS Moore R Johnson BL Jr Platt R Academic Medical Center Consortium Sepsis Project Working Group: Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997, 278:234-240. 10.1001/jama.278.3.234 9218672
7. Wichmann MW Inthorn D Andress HJ Schildberg FW: Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome. Intensive Care Med 2000, 26:167-172. 10.1007/s001340050041 10784304
8. Finfer S Bellomo R Lipman J French C Dobb G Myburgh J: Adult-population incidence of severe sepsis in Australia and New Zealand intensive care units. Intensive Care Med 2004, 30:589-596. 10.1007/s00134-004-2157-0 14963646
9. Adrie C Alberti C Chaix-Couturier C Azoulay E De Lassence A Cohen Y Meshaka P Cheval C Thuong M Troché G Garrouste-Orgeas M Timsit JF: Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care 2005, 20:46-58. 10.1016/j.jcrc.2004.10.005 16015516
10. Silva E Pedro M de A Sogayar AC Mohovic T Silva CL Janiszewski M Cal RG de Sousa EF Abe TP de Andrade J de Matos JD Rezende E Assunção M Avezum A Rocha PC de Matos GF Bento AM Corrêa AD Vieira PC Knobel E Brazilian Sepsis Epidemiological Study: Brazilian Sepsis Epidemiological Study (BASES study) Crit Care 2004, 8:R251-R260, 522852 15312226 10.1186/cc2892
11. Padkin A Goldfrad C Brady AR Young D Black N Rowan K: Epidemiology of severe sepsis occurring in the first 24 h in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003, 31:2332-2338. 10.1097/01.CCM.0000085141.75513.2B 14501964
12. Alberti C Brun-Buisson C Burchardi H Martin C Goodman S Artigas A Sicignano A Palazzo M Moreno R Boulmé R Lepage E Le Gall R: Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002, 28:108-121. 10.1007/s00134-001-1143-z 11907653
13. Guidet B Aegerter P Gauzit R Meshaka P Dreyfuss D CUB-Rea Study Group: Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005, 127:942-951. 10.1378/chest.127.3.942 15764780
14. Martin GS Mannino DM Eaton S Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139 12700374
15. Raymond DP Pelletier SJ Crabtree TD Gleason TG Pruett TL Sawyer RG: Impact of bloodstream infection on outcomes among infected surgical inpatients. Ann Surg 2001, 233:549-555. 1421285 11303138 10.1097/ 00000658-200104000-00011
16. Zaoutis TE Argon J Chu J Berlin JA Walsh TJ Feudtner C: The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 2005, 41:1232-1239. 10.1086/496922 16206095
17. Morgan J Meltzer MI Plikaytis BD Sofair AN Huie-White S Wilcox S Harrison LH Seaberg EC Hajjeh RA Teutsch SM: Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005, 26:540-547. 10.1086/502581 16018429
18. Annane D Aegerter P Jars-Guincestre MC Guidet B CUB-Réa Network: Current epidemiology of septic shock: The CUB-Réa Network. Am J Crit Care Med 2003, 168:165-172. 10.1164/rccm.2201087
19. KnausAWA Draper EA Wagner DP Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/ 00003246-198510000-00009 3928249
20. Vincent JL Moreno R Takala J Willatts S De Mendonca A Bruining H Reinhart CK Suter PM Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751 8844239
21. Ferreira FL Bota DP Bross A Mélot C Vincent JL: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758. 10.1001/jama.286.14.1754 11594901
22. Girou E Stephan F Novara A Safar M Fagon JY: Risk factors and outcome of nosocomial infections: Results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998, 157:1151-1158. 9563733
23. Ascioglu S Rex JH de Pauw B Bennett JE Bille J Crokaert F Denning DW Donnelly JP Edwards JE Erjavec Z Fiere D Lortholary O Maertens J Meis JF Patterson TF Ritter J Selleslag D Shah PM Stevens DA Walsh TJ Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002, 34:7-14. 10.1086/323335 11731939
24. Vandewoude KH Blot SI Depuydt P Benoit D Temmerman W Colardyn F Vogelaers D: Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 2006, 10:R31. 1550813 16507158 10.1186/cc4823
25. Levy MM Fink MP Marshall JC Abraham E Angus D Cook D Cohen J Opal SM Vincent JL Ramsay G SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/ SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256. 10.1097/01.CCM.0000050454.01978.3B 12682500
26. Volk HD Immunodepression in the surgical patient and increased susceptibility to infection: Crit Care 2002, 6:279-281. 137302 12225595 10.1186/cc1507
27. Rangel-Frausto MS Martin MA Saiman L the NEMIS study group: High prevalence of Candida spp. on hands of healthcare workers in surgical and neonatal intensive care units: A multicenter study [abstract J106]. Proceedings and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy Orlando, Florida; 4 to 7 October 1994. Washington, DC: American Society for Microbiology 1994. 1994
28. Liu XY Xu Y Wen SK: Risk factors of iatrogenic fungal infection in intensive care unit. Chin J Nosocomiol 2005, 15:31-32.
29. Almirante B Rodríguez D Park BJ Cuenca-Estrella M Planes AM Almela M Mensa J Sanchez F Ayats J Gimenez M Saballs P Fridkin SK Morgan J Rodriguez-Tudela JL Warnock DW Pahissa A Barcelona Candidemia Project Study Group: Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2005, 43:1829-1235. 1081396 15815004 10.1128/JCM.43.4.1829-1835.2005
30. Cheng MF Yu KW Tang RB Fan YH Yang YL Hsieh KS Ho M Lo HJ: Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 2004, 48:33-37 10.1016/ j.diagmicrobio.2003.08.002 14761719
31. Trick WE Fridkin SK Edwards JR Hajjeh RA Gaynes RP National Nosocomial Infections Surveillance System Hospitals: Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002, 35:627-630. 10.1086/342300 12173140
32. Blumberg HM Jarvis WR Soucie JM Edwards JE Patterson JE Pfaller MA Rangel-Frausto MS Rinaldi MG Saiman L Wiblin RT Wenzel RP National Epidemiology of Mycoses Survey (NEMIS) Study Group: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey Clin Infect Dis 2001, 33:177-186. 10.1086/ 321811 11418877
33. Vincent JL Anaissie E Bruining H Demajo W el-Ebiary M Haber J Hiramatsu Y Nitenberg G Nystrom PO Pittet D Rogers T Sandven P Sganga G Schaller MD Solomkin J: Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 1998, 24:206-216. 10.1007/s001340050552 9565801
34. Diekema DJ Messer SA Brueggemann AB Coffman SL Doern GV Herwaldt LA Pfaller MA: Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol 2002, 40:1298-1302. 140380 11923348 10.1128/ JCM.40.4.1298-1302.2002
35. Nolla-Salas J Sitges-Serra A León-Gil C Martínez-González J León-Regidor MA Ibáñez-Lucía P Torres-Rodríguez JM: Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Intens Care Med 1997, 23:23-30. 10.1007/s001340050286
36. Morgan J Meltzer MI Plikaytis BD Sofair AN Huie-White S Wilcox S Harrison LH Seaberg EC Hajjeh RA Teutsch SM: Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005, 26:540-547. 10.1086/502581 16018429
37. Zaoutis TE Argon J Chu J Berlin JA Walsh TJ Feudtner C: The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis 2005, 41:1232-1239. 10.1086/496922 16206095
38. Digiovine B Chenoweth C Watts C Higgins M: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Me 1999, 160:976-981.
39. Blot SI Vandewoude KH Hoste EA Colardyn FA: Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 2002, 113:480-485. 10.1016/S0002-9343(02)01248-2 12427497